Abstract

The paper summarizes the history of the development of the guidance on risk assessment, including the roadmap under the Cartagena Protocol on Biosafety since 2008 until now. The aim and the contents of the roadmap for risk assessment of living modified organisms (LMOs) are described, in particular the five steps in the risk assessment process. After several rounds of discussions at the expert and political level, the guidance including the roadmap is currently revised taking into account the results of an in-depth practical testing process by the Parties, Non-Parties, and relevant organizations. The aim is to provide an improved version of the guidance for endorsement and broad support by the next meeting of the Parties to the Cartagena Protocol in December 2016.

Highlights

  • The paper summarizes the history of the development of the guidance on risk assessment, including the roadmap under the Cartagena Protocol on Biosafety since 2008 until now

  • After several rounds of discussions at the expert and political level, the guidance including the roadmap is currently revised taking into account the results of an in-depth practical testing process by the Parties, Non-Parties, and relevant organizations

  • Due to consistency with the Convention on Biological Diversity, the term living modified organisms (LMOs) is used in the Protocol, according to the definition, this means the same as the term genetically modified organisms (GMOs) in other regulatory frameworks

Read more

Summary

Helmut Gaugitsch*

Reviewed by: Wendy Craig, International Centre for Genetic Engineering and Biotechnology, Italy. The paper summarizes the history of the development of the guidance on risk assessment, including the roadmap under the Cartagena Protocol on Biosafety since 2008 until now. The aim and the contents of the roadmap for risk assessment of living modified organisms (LMOs) are described, in particular the five steps in the risk assessment process. After several rounds of discussions at the expert and political level, the guidance including the roadmap is currently revised taking into account the results of an in-depth practical testing process by the Parties, Non-Parties, and relevant organizations. The aim is to provide an improved version of the guidance for endorsement and broad support by the meeting of the Parties to the Cartagena Protocol in December 2016

BRIEF HISTORY OF THE ROADMAP UNDER THE CARTAGENA PROTOCOL ON BIOSAFETY
Cartagena Roadmap for Risk Assessment
CONTENTS OF THE GUIDANCE ON RISK ASSESSMENT OF LMOs
THE CONTENTS OF THE ROADMAP FOR RISK ASSESSMENT OF LMOs
THE FIVE STEPS OF THE RISK ASSESSMENT PROCESS
THE CURRENT STAGE OF THE ROADMAP FOR RISK ASSESSMENT OF LMOs
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.